Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
FBRX
FBRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
FBRX News
GH Research (GHRS) Stock Surges 22.36% Ahead of Key Update
Jan 05 2026
NASDAQ.COM
Chardan Capital Reaffirms Buy Rating for Forte Biosciences with $61 Price Target
Nov 17 2025
Benzinga
Forte Biosciences, Inc. Announces Inducement Grants in Compliance with Nasdaq Listing Regulations
Oct 03 2025
Newsfilter
Forte Biosciences, Inc. to Present FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium
Sep 15 2025
Newsfilter
Forte Biosciences Prices $75 Mln Public Offering Of Common Stock And Pre-Funded Warrants
Jun 25 2025
NASDAQ.COM
Forte Biosciences Announces Pricing of $75 Million Public Offering
Jun 25 2025
Newsfilter
Forte Biosciences Announces Proposed Public Offering
Jun 24 2025
Newsfilter
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
Jun 23 2025
TipRanks
Forte Biosciences Stock (FBRX) Surges 25% on Positive Celiac Disease Trial Data
Jun 23 2025
TipRanks
Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study
Jun 23 2025
Newsfilter
Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
May 19 2025
Benzinga
Forte Biosciences price target lowered to $61 from $64 at Chardan
Apr 01 2025
Business Insider
Forte Biosciences files $300M mixed securities shelf
Mar 28 2025
Business Insider
FORTE BIOSCIENCES Earnings Preview: Recent $FBRX Insider Trading, Hedge Fund Activity, and More
Mar 15 2025
NASDAQ.COM
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
Feb 03 2025
Newsfilter
Why Forte Biosciences (FBRX) Stock Is Trading Lower
Dec 16 2024
Benzinga
Show More News
